1. Subcellular expression of maspin – from normal tissue to tumor cells
   Laura Banias et al, 2019, World Journal of Meta-Analysis CrossRef
2. Mini-Review: Current Bladder Cancer Treatment—The Need for Improvement
   Emily Gill et al, 2024, International Journal of Molecular Sciences CrossRef
3. Mitigative potential of rhoifolin against cisplatin prompted testicular toxicity: biochemical, spermatogenic and histological based analysis
   Faria Saher et al, 2023, Toxicology Research CrossRef
4. Chemoprotective effect of vitexin against cisplatin-induced biochemical, spermatological, steroidogenic, hormonal, apoptotic and histopathological damages in the testes of Sprague-Dawley rats
   Muhammad Umar Ijaz et al, 2022, Saudi Pharmaceutical Journal CrossRef
5. Knockdown of HMGN5 increases the chemosensitivity of human urothelial bladder cancer cells to cisplatin by targeting PI3K/Akt signaling
   Yu Gan et al, 2017, Oncology Letters CrossRef
6. Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer
   Zhiwen Xu et al, 2023, Science Translational Medicine CrossRef
7. Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis
   Chunyu Zhang et al, 2021, Frontiers in Oncology CrossRef
8. lncRNA and Mechanisms of Drug Resistance in Cancers of the Genitourinary System
   Dominik A. Barth et al, 2020, Cancers CrossRef
9. Apocynin alleviates cisplatin‐induced testicular cytotoxicity by regulating oxidative stress and apoptosis in rats
   Kutay M. Köroğlu et al, 2019, Andrologia CrossRef
10. Anti-tumor activity of cediranib, a pan-vascular endothelial growth factor receptor inhibitor, in pancreatic ductal adenocarcinoma cells
    Majid Momeny et al, 2020, Cellular Oncology CrossRef